These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11834496)

  • 1. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure.
    Li YY; Kadokami T; Wang P; McTiernan CF; Feldman AM
    Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H983-9. PubMed ID: 11834496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
    Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.
    Li YY; Feldman AM
    Drugs; 2001; 61(9):1239-52. PubMed ID: 11511020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices.
    Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM
    Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury.
    Falk V; Soccal PM; Grünenfelder J; Hoyt G; Walther T; Robbins RC
    Eur J Cardiothorac Surg; 2002 Jul; 22(1):53-8. PubMed ID: 12103373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice.
    Corbel M; Lanchou J; Germain N; Malledant Y; Boichot E; Lagente V
    Eur J Pharmacol; 2001 Aug; 426(1-2):113-21. PubMed ID: 11525779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.
    Bradham WS; Moe G; Wendt KA; Scott AA; Konig A; Romanova M; Naik G; Spinale FG
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1288-95. PubMed ID: 11893563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
    Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
    Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
    Voloshenyuk TG; Gardner JD
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
    Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
    Van Roy M; Van Lint P; Van Laere I; Wielockx B; Wilson C; López-Otin C; Shapiro S; Libert C
    Mol Cancer Ther; 2007 Sep; 6(9):2563-71. PubMed ID: 17876053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
    Kassiri Z; Oudit GY; Sanchez O; Dawood F; Mohammed FF; Nuttall RK; Edwards DR; Liu PP; Backx PH; Khokha R
    Circ Res; 2005 Aug; 97(4):380-90. PubMed ID: 16037568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.
    El Hajj EC; El Hajj MC; Ninh VK; Gardner JD
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H463-H473. PubMed ID: 29775412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
    Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
    J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibition and the prevention of heart failure.
    Lee RT
    Trends Cardiovasc Med; 2001 Jul; 11(5):202-5. PubMed ID: 11597832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling myocardial matrix remodeling: implications for heart failure.
    Rao VU; Spinale FG
    Cardiol Rev; 1999; 7(3):136-43. PubMed ID: 10423664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes.
    Diwan A; Dibbs Z; Nemoto S; DeFreitas G; Carabello BA; Sivasubramanian N; Wilson EM; Spinale FG; Mann DL
    Circulation; 2004 Jan; 109(2):262-8. PubMed ID: 14699008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.
    Wielockx B; Lannoy K; Shapiro SD; Itoh T; Itohara S; Vandekerckhove J; Libert C
    Nat Med; 2001 Nov; 7(11):1202-8. PubMed ID: 11689884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model.
    Mori S; Gibson G; McTiernan CF
    J Card Fail; 2006 May; 12(4):314-25. PubMed ID: 16679266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor.
    Sivasubramanian N; Coker ML; Kurrelmeyer KM; MacLellan WR; DeMayo FJ; Spinale FG; Mann DL
    Circulation; 2001 Aug; 104(7):826-31. PubMed ID: 11502710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.